Sign in
4

Changes in Ownership

ENDRA Life Sciences Inc. Filed Acc 0001209191-20-058450

Chief Commercial Officer sold 10,000 shares at $0.81 ($8,100)

From the SEC's structured data for this filing

Trades in this filing

Maloberti Renaud Bertrand · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-11-13 Sale : show line 1 in the form −10,000 $0.81 $8,100 66,580 D
Open-market sales · 10,000 sh · avg $0.81 · $8,100
Loading xslF345X03/doc4.xml…